Vyvanse and Lung transplant rejection - from FDA reports


Summary

There is no Lung transplant rejection reported by people who take Vyvanse yet. We study 2,148 people who have side effects while taking Vyvanse from FDA. Find out below who they are, when they have Lung transplant rejection and more.

What to expect?

If you take Vyvanse and have Lung transplant rejection, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Vyvanse and have Lung transplant rejection

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

Vyvanse

Vyvanse has active ingredients of lisdexamfetamine dimesylate. It is often used in attention deficit hyperactivity disorder. (latest outcomes from Vyvanse 13,789 users)

Lung Transplant Rejection

Lung transplant rejection (failure of lung transplant) has been reported by people with lung transplant, immunodeficiency disorders, cystic fibrosis, lung transplant rejection, pseudomonas infection (latest reports from 396 Lung transplant rejection patients).

On Feb, 25, 2017

No report is found.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Lung transplant rejection when taking Vyvanse?

Browse all side effects of Vyvanse

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Lung transplant rejection

Lung transplant rejection

Could your condition cause Lung transplant rejection

Lung transplant rejection

Related studies

Can you answer these questions?

More questions for: Vyvanse, Lung transplant rejection

You may be interested in these reviews

More reviews for: Vyvanse, Lung transplant rejection